Vicore Pharma (Sweden) Buy Hold or Sell Recommendation
| VICO Stock | SEK 7.84 0.36 4.39% |
Assuming the 90 days trading horizon and your highly speculative risk level, our recommendation regarding Vicore Pharma Holding is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Vicore Pharma Holding given historical horizon and risk tolerance towards Vicore Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Vicore Pharma Holding, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Vicore Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Vicore and provide practical buy, sell, or hold advice based on investors' constraints. Vicore Pharma Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Vicore |
Execute Vicore Pharma Buy or Sell Advice
The Vicore recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Vicore Pharma Holding. Macroaxis does not own or have any residual interests in Vicore Pharma Holding or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Vicore Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Vicore Pharma Trading Alerts and Improvement Suggestions
| Vicore Pharma generated a negative expected return over the last 90 days | |
| Vicore Pharma has high historical volatility and very poor performance | |
| Vicore Pharma has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (296.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vicore Pharma Holding has accumulated about 215.97 M in cash with (265.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.1. | |
| Roughly 16.0% of the company outstanding shares are owned by insiders |
Vicore Pharma Returns Distribution Density
The distribution of Vicore Pharma's historical returns is an attempt to chart the uncertainty of Vicore Pharma's future price movements. The chart of the probability distribution of Vicore Pharma daily returns describes the distribution of returns around its average expected value. We use Vicore Pharma Holding price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Vicore Pharma returns is essential to provide solid investment advice for Vicore Pharma.
| Mean Return | -0.8 | Value At Risk | -4.39 | Potential Upside | 4.46 | Standard Deviation | 6.75 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Vicore Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Vicore Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Vicore Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Vicore Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Vicore stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.59 | |
β | Beta against Dow Jones | -1.72 | |
σ | Overall volatility | 6.75 | |
Ir | Information ratio | -0.14 |
Vicore Pharma Volatility Alert
Vicore Pharma Holding is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Vicore Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Vicore Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Vicore Pharma Fundamentals Vs Peers
Comparing Vicore Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Vicore Pharma's direct or indirect competition across all of the common fundamentals between Vicore Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Vicore Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Vicore Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Vicore Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Vicore Pharma to competition |
| Fundamentals | Vicore Pharma | Peer Average |
| Return On Equity | -0.99 | -0.31 |
| Return On Asset | -0.49 | -0.14 |
| Current Valuation | 1.22 B | 16.62 B |
| Shares Outstanding | 81.85 M | 571.82 M |
| Shares Owned By Insiders | 16.14 % | 10.09 % |
| Shares Owned By Institutions | 51.89 % | 39.21 % |
| Price To Earning | 163.82 X | 28.72 X |
| Price To Book | 8.67 X | 9.51 X |
| EBITDA | (293.13 M) | 3.9 B |
| Net Income | (296.48 M) | 570.98 M |
| Cash And Equivalents | 215.97 M | 2.7 B |
| Cash Per Share | 5.10 X | 5.01 X |
| Total Debt | 320 K | 5.32 B |
| Current Ratio | 19.83 X | 2.16 X |
| Book Value Per Share | 2.24 X | 1.93 K |
| Cash Flow From Operations | (265.17 M) | 971.22 M |
| Earnings Per Share | (4.76) X | 3.12 X |
| Target Price | 69.6 | |
| Number Of Employees | 23 | 18.84 K |
| Beta | 0.59 | -0.15 |
| Market Capitalization | 1.26 B | 19.03 B |
| Total Asset | 451.17 M | 29.47 B |
| Net Asset | 451.17 M |
Vicore Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Vicore . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Vicore Pharma Buy or Sell Advice
When is the right time to buy or sell Vicore Pharma Holding? Buying financial instruments such as Vicore Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Vicore Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Electronics Thematic Idea Now
Electronics
Companies manufacturing electronic appliances and goods. The Electronics theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronics Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Vicore Stock Analysis
When running Vicore Pharma's price analysis, check to measure Vicore Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicore Pharma is operating at the current time. Most of Vicore Pharma's value examination focuses on studying past and present price action to predict the probability of Vicore Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicore Pharma's price. Additionally, you may evaluate how the addition of Vicore Pharma to your portfolios can decrease your overall portfolio volatility.